The AI osteoporosis screening tools market is estimated at USD 460.0 million in 2026 and is forecast to register a 9.5% CAGR between 2026 and 2036. In 2026, AI-enabled DXA image analysis holds 46.0% within the product segment and hospitals & diagnostic centers represent 48.0% of the end user category.